Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 9 Observational 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 2 Esophageal Neoplasms 2 Stereotactic Body Radiation Therapy 1 Lung Neoplasms 1 Liver Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Blood Specimen Collection 32 Surveys and Questionnaires 24 Radiotherapy 12 Gene Expression Profiling 12 Drug Therapy 12 Surgical Procedures, Operative 11 Bronchoscopy 10 Magnetic Resonance Spectroscopy 9 Immunotherapy 9 Immunohistochemistry 9 Tomography, X-Ray Computed 8 Specimen Handling 8 Observation 8 Amplified Fragment Length Polymorphism Analysis 8 Polymerase Chain Reaction 7 pembrolizumab 6 Psychiatric Rehabilitation 6 Interviews as Topic 6 Carboplatin 6 Thoracic Surgery, Video-Assisted 5 Reverse Transcriptase Polymerase Chain Reaction 5 Microarray Analysis 5 Liquid Biopsy 5 Chemoradiotherapy 5 Bevacizumab 5 durvalumab 4 Therapeutics 4 Paclitaxel 4 Nivolumab 4 Ipilimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Lung Neoplasms × anlotinib × Clear all

NCT05319886 2022-05-20

AP

The First Affiliated Hospital of Xinxiang Medical College

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡